Independent cancer second opinion for patients in the UAE and the Gulf
For patients and expatriate families in Dubai, Abu Dhabi, Riyadh, Doha and Kuwait City. Kim reviews molecular reports and searches US, UK and EU trials before you decide whether to travel for care.
What Kim reviews
- Pathology and tumor profiling (NGS) reports, including FoundationOne, Caris, Tempus and Guardant360
- Signatera and other ctDNA results
- Clinical trials that fit your molecular profile, locally and internationally
- Written questions and evidence your oncologist can act on
Price and scheduling
Every engagement starts with a free 15-minute call. No records or payment needed, and no obligation. The Clarity Report is USD $2,000 (about AED 7,350). Active Case Management: $4,500 / month; Concierge Advisory: $7,500 / month.
Video calls in GST / AST. Paid receipts are suitable for Daman, ADNIC, Bupa Global, AXA Gulf, and other regional private medical insurance reimbursement.
All fees are in US dollars and payable online by card. Calls are scheduled to fit your time zone. Records in languages other than English may require translation before review.
Calls are with Kim Lockheimer, PhD, DFM, Chief Scientific Officer. Prices in local currency: /ae/pricing.
Advisory only: diagnosis and treatment stay with your treating oncologist.
Guides for patients
- Getting a private cancer second opinion in Dubai and the UAE
- FoundationOne report explained
- How to read Signatera test results